biomarker panel
InfanDx Restructures After Halting Development of Hypoxic-Ischemic Encephalopathy Test
An in-depth analysis of biomarker validation study results for the firm's hypoxic-ischemic encephalopathy early detection tests raised doubts about its generalizability.
Biocare Medical Acquires Empire Genomics
The company believes its existing technology portfolio will be complemented by Empire's molecular probe business, better aiding cancer research and diagnostics.
SeekIn Nabs CE Mark for Cancer Assay
The biotech firm said its inexpensive and noninvasive test improves on existing screening methods and could help expand access to early cancer detection.
Valted Seq Lands Exclusive Rights to Evaluate Johns Hopkins Neurodegenerative Disease Dx Assays
The biomarker assays could one day be used as companion diagnostics for new treatments of Parkinson's and related diseases.
Neurodegenerative Disease Testing Firm CND Life Sciences Closes $2.4M Seed Financing Round
The financing will go toward the expansion of the company's laboratory operations and acceleration of the sales and marketing efforts of its Syn-One Test.